TMPRSS2 is a target for prospective therapeutic interventions against COVID-19 as it is an essential part of several biological processes, including viral entry by priming the S protein of viruses like SARS-CoV and SARS-CoV-2, crucial for their infectivity [52]. This evidence concerns the gene PROS1 and COVID-19.